Ardena
European CDMO and CRO offering bioanalysis alongside drug substance, drug product and formulation development.
55 contract research organizations in our directory list a site in Europe, across 14 countries. 29 report GLP capability and 5 report AAALAC accreditation. Compare services, species and accreditations below, and contact labs directly from their profiles.
Europe offers preclinical CROs in nearly every major country, with particular depth in the United Kingdom, Germany, France, the Netherlands, Ireland and Scandinavia, and growing capacity in Central Europe, including Hungary and Poland.
EU member states follow Directive 2010/63/EU on animal research, and every country here adheres to the OECD Mutual Acceptance of Data system, so GLP studies run in Europe are accepted by FDA for US filings. Species availability and nonhuman primate import rules vary by country.
Among the CROs listed in Europe, the most common services are In Vivo Efficacy, Bioanalysis, Oncology Models and GLP Toxicology. The species they most often work with are Mouse, Rat and Rabbit.
Showing 55 CROs with a site in Europe. Order rotates daily so no lab is permanently listed first.
European CDMO and CRO offering bioanalysis alongside drug substance, drug product and formulation development.
Danish preclinical CRO and peptide discovery company known for metabolic, liver and kidney disease models with AI-supported histology and 3D imaging readouts.
Ophthalmology-focused preclinical CRO offering retinal and anterior segment disease models, ocular dosing and functional readouts.
German preclinical CRO offering in vivo pharmacology, pharmacokinetic and exploratory safety studies.
Preclinical CRO near Toulouse specializing in metabolic disease pharmacology, including obesity, diabetes and NASH/MASH models.
French preclinical CRO offering in vivo pharmacology in neuroscience, pain and dermatology, plus related safety studies.
Toxicology and safety consultancy supporting nonclinical strategy, study design and regulatory submissions for drug developers.
German DMPK CRO offering in vitro ADME, in vivo pharmacokinetics and bioanalysis for discovery and early development.
Barcelona bioanalytical laboratory supporting preclinical and clinical studies with regulated LC-MS/MS and ligand binding assays.
Independent German preclinical CRO conducting GLP toxicology, reproductive toxicology, carcinogenicity and safety pharmacology studies across rodent and non-rodent species.
Danish preclinical imaging CRO offering PET, SPECT, CT and MRI studies, radiopharmaceutical development support and oncology efficacy models.
Preclinical CRO near Lyon with core expertise in nonhuman primate models, including BSL-3 infectious disease, biodistribution and custom proof-of-concept studies.
Translational neuroscience CRO with sites in the UK, Ireland and Canada offering CNS disease models, EEG and behavioral pharmacology.
Munich-area contract laboratory providing GLP toxicology, genetic toxicology, biocompatibility and microbiology testing for pharmaceutical, chemical and medical device sponsors.
French CRO specializing in in vivo infection models for antibacterial and antifungal drug development.
Berlin oncology CRO with a large collection of patient-derived xenograft models for in vivo efficacy and biomarker studies.
Czech analytical and bioanalytical CRO supporting nonclinical and clinical studies.
Lyon oncology CRO providing in vitro and in vivo proof-of-concept studies for anticancer agents, including resistant tumor models.
Preclinical CRO in Northern Ireland, part of QIMA Life Sciences, running non-GLP rodent PK, dose range finding, biodistribution and disease model studies.
Lyon-based company creating genetically engineered and humanized rodent models, with catalog models and in vivo research services.
UK bioanalytical CRO providing regulated small and large molecule bioanalysis for preclinical and clinical studies.
Independent Danish CRO focused on early in vivo pharmacology in rodents, with particular expertise in mouse cancer and immuno-oncology models.
Musculoskeletal research institute performing preclinical orthopedic and trauma studies, including large animal bone and implant models, for industry partners.
Danish non-profit research CRO offering customised cell models, assays and translational research services.
Non-clinical CRO near Milan and part of the NMS Group, offering GLP safety assessment and toxicology, safety pharmacology and preclinical regulatory consulting to move candidates toward IND/CTA.
French CRO combining early clinical development with preclinical pharmacology, offering CNS and cardiovascular safety pharmacology and translational neuroscience models.
Finnish preclinical CRO focused on bone and joint disease, bone metastasis and oncology models, including osteoarthritis and osteoporosis efficacy studies.
Polish drug discovery CRO providing integrated chemistry, biology, DMPK and translational research services.
Spanish translational research center offering GLP and non-GLP large animal studies, device validation, advanced imaging and surgical training.
Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.
Spanish analytical and bioanalytical CRO providing GLP small and large molecule bioanalysis and CMC testing.
Hungarian non-clinical CRO founded in 1982 offering GLP general, genetic and reproductive toxicology for pharmaceutical, chemical and agrochemical sponsors.
French neuroscience CRO dedicated to in vitro and in vivo models of neurodegenerative and neurological disease, with a US office.
Independent UK preclinical CRO offering GLP general, reproductive and juvenile toxicology studies for pharmaceutical and biotech sponsors.
Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.
French translational oncology CRO built around patient-derived xenograft models, with drug response and biomarker discovery services.
Italian GLP CRO near Rome providing regulatory toxicology and safety studies for pharmaceuticals, chemicals and agrochemicals.
Belgian CRO for preclinical surgical studies and surgical training in large animals, with operating theatres, ICU and fluoroscopy.
GLP-accredited preclinical CRO headquartered in Denmark with sites in Sweden, Austria and the UK. Known for Gottingen minipig work and regulatory toxicology, with discovery pharmacology including CNS and…
French CRO specializing in analytics for gene and cell therapies, including GLP biodistribution, vector shedding and anti-AAV immunogenicity assays.
Ophthalmology-dedicated CRO near Nice offering ocular efficacy models, GLP ocular safety and PK, bioanalysis and clinical services.
Fraunhofer institute for toxicology and experimental medicine providing GLP inhalation toxicology, respiratory disease models and translational research under contract.
Swedish CRO specializing in rodent models of arthritis, autoimmunity and inflammation.
French CRO focused on neurodegeneration and brain aging, offering in vivo models and readouts for Alzheimer's and related diseases.
UK bioanalytical laboratory offering LC-MS/MS method development, validation and regulated sample analysis.
French neuroscience CRO offering in vitro and in vivo models for neurological and neurodegenerative drug discovery.
German CRO offering integrated discovery, DMPK, bioanalysis and early development services across sites in Germany and France.
French preclinical CRO specializing in bone, joint and inflammatory disease models with histology and imaging readouts.
Preclinical in vivo pharmacology with CNS/behavioral expertise and multiple disease models.
For a full checklist, see our CRO selection guide.